187 related articles for article (PubMed ID: 33565307)
1. Serologic screening and infectious diseases consultation in renal transplant candidates for measles, mumps, rubella and varicella.
Seckin ZI; Libertin CR; Brumble LM
Rom J Intern Med; 2021 May; 59(2):159-165. PubMed ID: 33565307
[No Abstract] [Full Text] [Related]
2. Serologic screening and infectious disease consultation (IDC): Indicated in heart, lung, liver (HLL) solid organ transplants (SOT) for measles, mumps, rubella, and varicella.
Seckin ZI; Brumble LM; Libertin CR
Transpl Infect Dis; 2020 Feb; 22(1):e13202. PubMed ID: 31647159
[TBL] [Abstract][Full Text] [Related]
3. Establishing best practices in measles, mumps, and rubella serologic screening for kidney transplant candidates.
Ramakrishna JM; Brumble LM; Larimore KL; Wadei HM; Jarmi T; Libertin CR
Transpl Infect Dis; 2021 Jun; 23(3):e13529. PubMed ID: 33248010
[TBL] [Abstract][Full Text] [Related]
4. Serologic evaluation of vaccine preventable infections and vaccination rates in kidney transplant candidates.
Schneider S; Carlson A; Sirandas B; Clark B; Truax C
Transpl Infect Dis; 2022 Dec; 24(6):e13973. PubMed ID: 36263508
[TBL] [Abstract][Full Text] [Related]
5. Safety and Immunogenicity of Live Viral Vaccines in a Multicenter Cohort of Pediatric Transplant Recipients.
Feldman AG; Beaty BL; Ferrolino JA; Maron G; Weidner HK; Ali SA; Bitterfeld L; Boulware MA; Campbell KM; Carr E; Chapman S; Chang YC; Cunningham R; Dallas RH; Dantuluri KL; Domenick BN; Ebel NH; Elisofon S; Fawaz R; Foca M; Gans HA; Gopalareddy VV; Gu C; Gupta NA; Harmann K; Hollenbeck J; Huppler AR; Jaramillo C; Kasi N; Kerkar N; Lerret S; Lobritto SJ; Lopez MJ; Marini E; Mavis A; Mehra S; Moats L; Mohandas S; Munoz FM; Mysore KR; Onsan C; Ovchinsky N; Perkins K; Postma S; Pratscher L; Rand EB; Rowe RK; Schultz D; Sear K; Sell ML; Sharma T; Stoll J; Vang M; Villarin D; Weaver C; Wood P; Woodford-Berry O; Yanni G; Danziger-Isakov LA
JAMA Netw Open; 2023 Oct; 6(10):e2337602. PubMed ID: 37824141
[TBL] [Abstract][Full Text] [Related]
6. Immunity Rates of Live Viral Vaccines in Pediatric Renal Transplant Candidates: A Single-Center Experience.
Orhan Kilic B; Baskin E; Gulleroglu K; Kilic S; Aydin B; Akbulut O; Haberal M
Exp Clin Transplant; 2024 Jan; 22(Suppl 1):275-280. PubMed ID: 38385412
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalence of Measles, Mumps, Rubella, and Varicella-Zoster Virus and Seroresponse to the Vaccinations in Adult Solid Organ Transplant Candidates.
Javaid H; Prasad P; De Golovine A; Hasbun R; Jyothula S; Machicao V; Bynon JS; Ostrosky L; Nigo M
Transplantation; 2023 Oct; 107(10):2279-2284. PubMed ID: 37309028
[TBL] [Abstract][Full Text] [Related]
8. Seroprevalence of measles, mumps, rubella, and varicella zoster virus antibodies among healthcare students: analysis of vaccine efficacy and cost-effectiveness.
Ödemiş Í; Köse Ş; Akbulut Í; Albayrak H
Rev Esp Quimioter; 2019 Dec; 32(6):525-531. PubMed ID: 31642641
[TBL] [Abstract][Full Text] [Related]
9. Reactogenicity and immunogenicity of a live attenuated tetravalent measles-mumps-rubella-varicella (MMRV) vaccine.
Nolan T; McIntyre P; Roberton D; Descamps D
Vaccine; 2002 Dec; 21(3-4):281-9. PubMed ID: 12450703
[TBL] [Abstract][Full Text] [Related]
10. Immunogenicity and reactogenicity of a single dose of live attenuated varicella vaccine and a booster dose of measles-mumps-rubella vaccine given concomitantly at 12 years of age.
Parment PA; Svahn A; Rudén U; Bråkenhielm G; Storsaeter J; Akesson L; Linde A
Scand J Infect Dis; 2003; 35(10):736-42. PubMed ID: 14606613
[TBL] [Abstract][Full Text] [Related]
11. Do HIV-positive adult immigrants need to be screened for measles-mumps-rubella and varicella zoster virus immunization?
Llenas-García J; Rubio R; Hernando A; Arrazola P; Pulido F
AIDS Care; 2013 Aug; 25(8):980-9. PubMed ID: 23244745
[TBL] [Abstract][Full Text] [Related]
12. Vaccine-Preventable Diseases In Pediatric Patients: A Review Of Measles, Mumps, Rubella, And Varicella.
Levine DA
Pediatr Emerg Med Pract; 2016 Dec; 13(12):1-20. PubMed ID: 27893360
[TBL] [Abstract][Full Text] [Related]
13. Combination measles, mumps, rubella and varicella vaccine.
Arbeter AM; Baker L; Starr SE; Levine BL; Books E; Plotkin SA
Pediatrics; 1986 Oct; 78(4 Pt 2):742-7. PubMed ID: 3763291
[TBL] [Abstract][Full Text] [Related]
14. Use of combination measles, mumps, rubella, and varicella vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Marin M; Broder KR; Temte JL; Snider DE; Seward JF;
MMWR Recomm Rep; 2010 May; 59(RR-3):1-12. PubMed ID: 20448530
[TBL] [Abstract][Full Text] [Related]
15. Immunogenicity and safety assessments after one and two doses of a refrigerator-stable tetravalent measles-mumps-rubella-varicella vaccine in healthy children during the second year of life.
Schuster V; Otto W; Maurer L; Tcherepnine P; Pfletschinger U; Kindler K; Soemantri P; Walther U; Macholdt U; Douha M; Pierson P; Willems P
Pediatr Infect Dis J; 2008 Aug; 27(8):724-30. PubMed ID: 18600190
[TBL] [Abstract][Full Text] [Related]
16. Performance Characteristics of a Multiplex Flow Immunoassay for Detection of IgG-Class Antibodies to Measles, Mumps, Rubella, and Varicella-Zoster Viruses in Presumptively Immune Health Care Workers.
Theel ES; Sorenson M; Rahman C; Granger D; Vaughn A; Breeher L
J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 32024728
[TBL] [Abstract][Full Text] [Related]
17. Immunogenicity and reactogenicity of tetravalent vaccine for measles, mumps, rubella and varicella (MMRV) in healthy children: a meta-analysis of randomized controlled trials.
Leung JH; Hirai HW; Tsoi KK
Expert Rev Vaccines; 2015; 14(8):1149-57. PubMed ID: 26081133
[TBL] [Abstract][Full Text] [Related]
18. The safety and immunogenicity of a quadrivalent measles, mumps, rubella and varicella vaccine in healthy children: a study of manufacturing consistency and persistence of antibody.
Lieberman JM; Williams WR; Miller JM; Black S; Shinefield H; Henderson F; Marchant CD; Werzberger A; Halperin S; Hartzel J; Klopfer S; Schödel F; Kuter BJ;
Pediatr Infect Dis J; 2006 Jul; 25(7):615-22. PubMed ID: 16804432
[TBL] [Abstract][Full Text] [Related]
19. Waning of maternal antibodies against measles, mumps, rubella, and varicella in communities with contrasting vaccination coverage.
Waaijenborg S; Hahné SJ; Mollema L; Smits GP; Berbers GA; van der Klis FR; de Melker HE; Wallinga J
J Infect Dis; 2013 Jul; 208(1):10-6. PubMed ID: 23661802
[TBL] [Abstract][Full Text] [Related]
20. Seroprevalence of measles, mumps, rubella and varicella among staff of a hospital in Riyadh, Saudi Arabia.
Abbas M; Atwa M; Emara A
J Egypt Public Health Assoc; 2007; 82(3-4):283-97. PubMed ID: 18410713
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
